Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 31Neoplasms 20Motor Activity 12Lung Neoplasms 7Fatigue 7Colorectal Neoplasms 6Anxiety Disorders 6Stomach Neoplasms 4Polycystic Ovary Syndrome 4Pain, Postoperative 4Pain 4Depression 4Carcinoma, Hepatocellular 4Thyroid Neoplasms 3Sleep Initiation and Maintenance Disorders 3Prostatic Neoplasms 3Malnutrition 3Vomiting 2Urinary Incontinence 2Stomatitis 2Rectal Neoplasms 2Peritoneal Neoplasms 2Parasomnias 2Ovarian Neoplasms 2Nausea 2Lymphedema 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Hot Flashes 2Hematologic Neoplasms 2

Interventions

Standard of Care 6Surveys and Questionnaires 2Interviews as Topic 2zaleplon 1olanzapine-fluoxetine combination 1Videotape Recording 1Rehabilitation 1Referral and Consultation 1Olanzapine 1Neoadjuvant Therapy 1Health Services Needs and Demand 1Fluoxetine 1Decision Support Techniques 1Counseling 1Control Groups 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Advanced Cancer × Control Groups × Clear all
NCT04407013 2022-09-10

Enhanced Supportive Care for Advanced Cancer Patients: Evaluation of Standardized Care Pathway

Yonsei University

Phase NA Unknown
780 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡